Records containing: Overweight or Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-10A Phase 4, Prospective, Open-Label, Single-Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice.
-
CLINICAL_TRIALS study record update · 2026-02-09The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment by a Single-center, Randomized, Placebo-controlled Interventional Study (Include Elderly Patients With Obesity or Overweight)
-
CLINICAL_TRIALS study record update · 2026-02-02Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women: A Pilot Trial
-
CLINICAL_TRIALS study record update · 2026-01-26Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
-
CLINICAL_TRIALS study record update · 2026-01-16A Randomized, Double-blind, Placebo-controlled, Multiple-ascending-dose Phase Ic Study Evaluating the Safety, Tolerability, and Pharmacokinetics of ZT002 Injection in Participants With Overweight or Obesity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-08Hepatic Energy Fluxes, NASH, and Vertical Sleeve Gastrectomy
-
CLINICAL_TRIALS study record update · 2025-12-31A Phase 1 Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI3032 After Multiple Ascending Doses in Participants With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2025-12-22A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of MDR-001 Administered Orally Over 52 Weeks in Participants With Overweight or Obesity (MOBILE)
-
CLINICAL_TRIALS study record update · 2025-12-19A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single/Multiple-dose Study to Evaluate the Tolerability, Safety and Pharmacokinetics of BGM1812 in Healthy and Non-diabetic Overweight or Obese Chinese Participants
-
CLINICAL_TRIALS study record update · 2025-12-18Cognitive Behavioral Therapy for Adolescents With Bulimia Nervosa and Higher Weight (Online Treatment Study)
-
CLINICAL_TRIALS study record update · 2025-12-18Diabetes Prevention Program Feasibility Study of Breastfeeding - Electronic Monitoring of Mom's Schedule 2.0
-
CLINICAL_TRIALS study record update · 2025-12-10A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of ZT002 Injection in Subjects With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2025-12-08Technology-Supported Treatment of Sleep Apnea in Prediabetes
-
CLINICAL_TRIALS study record update · 2025-12-04Binge Eating Self-help for Teens (BEST): A Pilot and Feasibility Test of an Online Behavioral Intervention for Adolescents With Binge Eating and Elevated Weight
-
CLINICAL_TRIALS study record update · 2025-12-03Connectome-based Neurofeedback of the Craving Network to Reduce Food Cue Reactivity
-
CLINICAL_TRIALS study record update · 2025-12-02Biological Sample Repository for Gastrointestinal Disorders
-
CLINICAL_TRIALS study record update · 2025-11-28A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CT-996 in Overweight/Obese Participants and in Patients With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2025-11-25A Phase 2b, Double-Blind Study to Investigate the Effect of Retatrutide on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-11-20A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWN109 Tablets in Healthy Adult Participants
-
CLINICAL_TRIALS study record update · 2025-11-18Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects: a Randomized, Double-blind, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2025-11-17A Phase I Clinical Study Comparing the Relative Bioavailability, Safety and Tolerability of the First-generation and Second-generation Formulations of HRS9531 Tablets and Exploring the Safety, Tolerability and Pharmacokinetic Characteristics of Single-dose Escalation of the Second-generation Formulation
-
CLINICAL_TRIALS study record update · 2025-11-14Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
-
CLINICAL_TRIALS study record update · 2025-11-06A Phase 1, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
-
CLINICAL_TRIALS study record update · 2025-11-06A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2025-11-05A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral Orforglipron Compared With Placebo in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1)